Physician profile
Krupal Patel
NPI 1457882821
$2,384.56
in general payments reported to CMS, 2019-2025
11 companies · $770 in 2025
The $770 reported for 2025 was more than what 83% of Plastic Surgery Within The Head & Neck providers received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $125 · 2022: $921 · 2023: $424 · 2024: $145 · 2025: $770.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,243 · Entertainment: $93.36 · Education: $2.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,242.56 |
| Entertainment | $93.36 |
| Education | $2.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $789.91 | 2022 | |
| Kls-Martin L.P. | $403.29 | 2020-2023 | |
| Janssen Research & Development, LLC | $325.73 | 2025 | |
| Aveo Pharmaceuticals, INC. | $210.36 | 2025 | |
| Sun Pharmaceutical Industries INC. | $145.80 | 2023 | |
| Coherus Oncology, INC. | $142.01 | 2024 | |
| Stryker Corporation | $130.74 | 2022 | |
| Regeneron Pharmaceuticals, INC. | $121.64 | 2025 | Libtayo |
| Tempus Ai, INC | $84.50 | 2025 | Xt Cdx |
| Astrazeneca Pharmaceuticals LP | $27.59 | 2025 | Imfinzi |
| Intuitive Surgical, INC. | $2.99 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krupal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.